USPTO serial 79276524
STARVANIP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2020
- Examiner
- FAIRBANKS, RONALD L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with STARVANIP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jori R. Fuller
Jori R. Fuller McDonnell Boehnen Hulbert & Berghoff LLP300 South Wacker DriveChicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of deep vein thrombosis; drugs for medical purposes, namely, drugs for the treatment of cerebral apoplexy, drugs for affecting metabolism, drugs for affecting the peripheral nervous system, anti-inflammatory drugs, immunomodulatory drugs, cardiovascular drugs, drugs for treatment of deep vein thrombosis, drugs for treatment of systemic emboliform, drugs for treatment of venous thromboembolism, drugs affecting the central nervous system, drugs for treatment of pulmonary embolism, antibiotic drugs, drugs for the treatment of cancer, and drugs effecting respiratory organs; medicines for human purposes, namely, medicines for the treatment of cerebral apoplexy, medicines for affecting metabolism, medicines for affecting the peripheral nervous system, anti-inflammatory medicines, immunomodulatory medicines, cardiovascular medicines, medicines for treatment of deep vein thrombosis, medicines for treatment of systemic emboliform, medicines for treatment of venous thromboembolism, medicines affecting the central nervous system, medicines for treatment of pulmonary embolism, antibiotic medicines, medicines for the treatment of cancer or resistant cancer, and medicines effecting respiratory organs; pharmaceutical preparations for the treatment of systemic emboliform; pharmaceutical preparations for the treatment of venous thromboembolism; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of pulmonary emboliform; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 1, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 20, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 2, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 11, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 24, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 24, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 24, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 24, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |